4-(6-Ethoxy-pyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-Nitro-4-(trifluoromethyl)benzyl alcohol, 98.0%, 1g

1-Benzyl-5-oxopyrrolidine-3-carboxylic Acid>98.0%(GC)(T)1g

3-(4-Bromothiophen-3-yl)benzaldehyde, 98%, 250mg

(S)-(9H-Fluoren-9-yl)methyl (1-chloro-3-methyl-1-oxobutan-2-yl)carbamate, 95.0%, 250mg

4-BOC-1-(3,5-DIMETHOXYPHENYL)-PIPERAZINE, 97.0%, 250mg

Colonna capillare per GC ROTI®Cap-1701, 50 m, 0.53 mm, 2.00 µm, 1 Pezzo(i)

ETHYL 4-(2-AMINOACETAMIDO)-3-METHOXYBENZOATE HCL, 97.0%, 100mg

2-Chlorobenzotrifluoride, 99.0%, 500g

[1-(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-piperidin-4-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 100mg

9-(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole, 98+%, 250mg

4,5-Dibromo-1,2-dimethyl-1H-imidazole, 95.0%, 10g

(S)-2-Amino-3-(3-methoxyphenyl)propionic acid, 95.0%, 1g